U.S. flag

An official website of the United States government

NM_000769.4(CYP2C19):c.681G>A (p.Pro227=) AND not provided

Germline classification:
Likely benign; other (2 submissions)
Last evaluated:
Aug 7, 2018
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000352637.14

Allele description [Variation Report for NM_000769.4(CYP2C19):c.681G>A (p.Pro227=)]

NM_000769.4(CYP2C19):c.681G>A (p.Pro227=)

Gene:
CYP2C19:cytochrome P450 family 2 subfamily C member 19 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q23.33
Genomic location:
Preferred name:
NM_000769.4(CYP2C19):c.681G>A (p.Pro227=)
Other names:
CYP2C19m1:CYP2C19*2
HGVS:
  • NC_000010.11:g.94781859G>A
  • NG_008384.3:g.24179G>A
  • NM_000769.4:c.681G>AMANE SELECT
  • NP_000760.1:p.Pro227=
  • NC_000010.10:g.96541616G>A
  • NM_000769.1:c.681G>A
  • NM_000769.2:c.681G>A
Links:
PharmGKB Clinical Annotation: 655384520; PharmGKB Clinical Annotation: 982038133; PharmGKB Clinical Annotation: 982038252; PharmGKB Clinical Annotation: 982040587; OMIM: 124020.0001; dbSNP: rs4244285
NCBI 1000 Genomes Browser:
rs4244285
Molecular consequence:
  • NM_000769.4:c.681G>A - synonymous variant - [Sequence Ontology: SO:0001819]
Functional consequence:
  • cryptic splice acceptor activation [PubMedVariation Ontology: 0375]
  • protein loss of function [Variation Ontology: 0043]
Observations:
275

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000331333Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL ClinVar v180209 classification definitions)
other
(Aug 7, 2018)
germlineclinical testing

Citation Link,

SCV005221959Breakthrough Genomics, Breakthrough Genomics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benigngermlinenot provided

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown275not providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providednot provided

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Eurofins Ntd Llc (ga), SCV000331333.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided275not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided275not providednot providednot provided

From Breakthrough Genomics, Breakthrough Genomics, SCV005221959.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024